Submitted by elizabethwu1 on Mon, 11/07/2016 - 2:55pm NCT02008357 Solanezumab United States Friday, February 28, 2014 – Saturday, December 31, 2022 1 150 Phase 3 Alzheimer's Disease Eli Lilly & Co. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.